The Clinical Translational (CT) Core addresses the challenges facing investigators who conduct human behavioral and biobehavioral research on IDD conditions, such as autism, fragile X syndrome, and Down syndrome. Participants can be difficult to recruit because of their relatively low prevalence in the general population. Moreover, once recruited, these participants require evaluations by professionals with specialized training to confirm diagnoses and determine whether inclusion/exclusion criteria are met. Recruitment of typically developing control participants can also be challenging, particularly for studies of young children that require biologic sampling or neuroimaging because parents are often reluctant to enroll. The CT Core is designed to help IDDRC investigators overcome these challenges by providing services that include participant recruitment, community outreach, initial diagnostic qualification, assessment of inclusion and exclusion criteria, and allocation of personnel and resources for these activities. The CT Core staff and resources dedicated to these activities will significantly diversify the available pool of participants;improve cost effectiveness efficiency, and productivity by sharing participant qualification characteristics across projects;and provide resources that are beyond the expertise or budget of specific investigators but are essential to the highest quality behavioral and biobehavioral science. The individuals and infrastructure associated with the proposed CT Core have provided similar services to many funded studies at the MIND Institute over the last dozen years, although these services were more limited in scope and were not previously integrated into a single organizational structure. The integration proposed and the expansion afforded by the support of the IDDRC U54 grant (and the additional institutional support of the MIND Institute and UC Davis) will increase efficiency, lower costs of services thereby encouraging greater use by IDDRC investigators, expand diagnostic evaluation services, and increase recruitment efforts, especially as regards the recruitment of ethnically, racially, and economically diverse participants. The primary objective of the CT Core is to establish and maintain an operational framework that is optimal for recruitment and diagnostic assessment and characterization of a diverse range of special and typical populations. We will achieve this objective by addressing the following Specific Aims: 1. Enhance recruitment of a diverse range of participants through a systematic process of community engagement, including multiple ethnicities, races, and economic backgrounds with both atypical and typical development across a wide age span. 2. Maintain a participant registry and tracking system that includes critical descriptive information, permitting investigators to select participants for recruitment who are most likely to meet specific eligibility criteria. 3. Provide experienced evaluators who can advise studies in best practices for diagnostic assessment and standardized measure selection, provide training in administration of standardized measures, establish initial reliability and ongoing monitoring of administration fidelity, and conduct specialized diagnostic assessments as needed.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54HD079125-01
Application #
8659014
Study Section
Special Emphasis Panel (ZHD1-DSR-H (50))
Project Start
2013-09-24
Project End
2018-06-30
Budget Start
2013-09-24
Budget End
2014-06-30
Support Year
1
Fiscal Year
2013
Total Cost
$188,853
Indirect Cost
$66,221
Name
University of California Davis
Department
Type
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Roberts, Jane E; Ezell, Jordan E; Fairchild, Amanda J et al. (2018) Biobehavioral composite of social aspects of anxiety in young adults with fragile X syndrome contrasted to autism spectrum disorder. Am J Med Genet B Neuropsychiatr Genet 177:665-675
Sowell, K D; Uriu-Adams, J Y; Van de Water, J et al. (2018) Implications of altered maternal cytokine concentrations on infant outcomes in children with prenatal alcohol exposure. Alcohol 68:49-58
Ly, Calvin; Greb, Alexandra C; Cameron, Lindsay P et al. (2018) Psychedelics Promote Structural and Functional Neural Plasticity. Cell Rep 23:3170-3182
Stahmer, Aubyn C; Suhrheinrich, Jessica; Schetter, Patricia L et al. (2018) Exploring multi-level system factors facilitating educator training and implementation of evidence-based practices (EBP): a study protocol. Implement Sci 13:3
McDuffie, Andrea; Banasik, Amy; Bullard, Lauren et al. (2018) Distance delivery of a spoken language intervention for school-aged and adolescent boys with fragile X syndrome. Dev Neurorehabil 21:48-63
Stamou, Marianna; Grodzki, Ana Cristina; van Oostrum, Marc et al. (2018) Fc gamma receptors are expressed in the developing rat brain and activate downstream signaling molecules upon cross-linking with immune complex. J Neuroinflammation 15:7
Avino, Thomas A; Barger, Nicole; Vargas, Martha V et al. (2018) Neuron numbers increase in the human amygdala from birth to adulthood, but not in autism. Proc Natl Acad Sci U S A 115:3710-3715
Miller, Meghan; Iosif, Ana-Maria; Young, Gregory S et al. (2018) Early Detection of ADHD: Insights From Infant Siblings of Children With Autism. J Clin Child Adolesc Psychol 47:737-744
Ozonoff, Sally; Gangi, Devon; Hanzel, Elise P et al. (2018) Onset patterns in autism: Variation across informants, methods, and timing. Autism Res 11:788-797
Del Hoyo Soriano, Laura; Thurman, Angela John; Abbeduto, Leonard (2018) Specificity: A Phenotypic Comparison of Communication-Relevant Domains Between Youth With Down Syndrome and Fragile X Syndrome. Front Genet 9:424

Showing the most recent 10 out of 175 publications